BrainPatch continues to contribute to the global scientific dialogue in mental health and neurotechnology.

Our Chief Science Officer, Dr Serhii Tukaiev, presented BrainPatch’s research at the 34th European Congress of Psychiatry (EPA 2026), held in Prague, Czech Republic, from March 28–31, 2026. The congress is one of Europe’s premier events in psychiatry, bringing together leading clinicians, researchers, and innovators in the field of mental health.

Dr Tukaiev’s presentation focused on BrainPatch’s assistive wearable neurotechnology designed to support individual mental well-being. The work highlights the intersection of neuroscience, digital health, and AI-driven approaches to mental health monitoring and intervention.

Importantly, this is not the first time BrainPatch has been represented at the EPA Congress. Dr Tukaiev has previously presented at the event, reflecting the company’s ongoing commitment to scientific excellence and long-term engagement with the international research community.

EPA 2026’s theme, “Mental Health: Improving Care and Expanding Horizons,” aligns closely with BrainPatch’s mission to develop accessible, science-based solutions for mental health support.

We are proud to continue contributing to the advancement of neurotechnology and to be part of the global effort to improve mental health care.